Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking

Addiction Biology

Volumn 18, Issue 4, 2013, Pages 633-643

  Velázquez Sánchez, Clara ^a   Ferragud, Antonio ^a   Ramos Miguel, Alfredo ^b   García Sevilla, Jesús A ^b   Canales, Juan J ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Addiction; cocaine; dopamine uptake blocker; relapse; therapy

Indexed keywords

3 A[BIS(4 FLUOROPHENYL)METHOXY]TROPANE; AHN 1055; AMPHETAMINE; BRAIN DERIVED GROWTH FACTOR; COCAINE; DOPAMINE UPTAKE INHIBITOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFORCEMENT; RELAPSE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ADDICTIVE; BENZTROPINE; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; MALE; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, LONG-EVANS; RECURRENCE; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84879461174     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00458.x     Document Type: Article

References (57)

1. Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH, (1997) Novel N-substituted 3 alpha-[bis(4′-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40: 4329-4339. (Pubitemid 28042312)
2. Alvaro-Bartolome M, La HR, Callado LF, Meana JJ, Garcia-Sevilla JA, (2011) Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats. Neuroscience 196: 1-15.
3. Bickel WK, Johnson RE, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, (1987) A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties. NIDA Res Monogr 76: 182-188. (Pubitemid 17167612)
4. Boronat MA, Garcia-Fuster MJ, Garcia-Sevilla JA, (2001) Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 134: 1263-1270. (Pubitemid 33097256)
5. Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y, (2005) Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 526: 36-50. (Pubitemid 41744104)
6. Cain ME, Denehy ED, Bardo MT, (2008) Individual differences in amphetamine self-administration: the role of the central nucleus of the amygdala. Neuropsychopharmacology 33: 1149-1161. (Pubitemid 351367536)
7. Capriles N, Rodaros D, Sorge RE, Stewart J, (2003) A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 168: 66-74. (Pubitemid 36851164)
8. Ciccocioppo R, Sanna PP, Weiss F, (2001) Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci U S A 98: 1976-1981. (Pubitemid 32165608)
9. Cornuz J, (2006) Treating tobacco use and dependence in clinical practice. Expert Opin Pharmacother 7: 783-792.
10. Curran T, Morgan JI, (1995) Fos: an immediate-early transcription factor in neurons. J Neurobiol 26: 403-412.
11. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, Katz JL, (2005) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25: 1889-1893. (Pubitemid 40289393)
12. Epstein DH, Preston KL, Stewart J, Shaham Y, (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189: 1-16. (Pubitemid 44607255)
13. Ferragud A, Velazquez-Sanchez C, Hernandez-Rabaza V, Nacher A, Merino V, Carda M, Murga J, Canales JJ, (2009) A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat. Psychopharmacology (Berl) 207: 281-289.
14. Garcia-Fuster MJ, Clinton SM, Watson SJ, Akil H, (2009) Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology 34: 1123-1134.
15. Garcia-Fuster MJ, Flagel SB, Mahmood ST, Mayo LM, Thompson RC, Watson SJ, Akil H, (2011) Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD. Neuropsychopharmacology 36: 2303-2317.
16. Garcia-Fuster MJ, Miralles A, Garcia-Sevilla JA, (2007) Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology 32: 399-411. (Pubitemid 46106946)
17. Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L, (2010) Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev 35: 157-171.
18. Gorelick DA, Gardner EL, Xi ZX, (2004) Agents in development for the management of cocaine abuse. Drugs 64: 1547-1573. (Pubitemid 38981839)
19. Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG, (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21: 522-526. (Pubitemid 32937435)
20. Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A, (1997) Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17: 485-488. (Pubitemid 28389189)
21. Gray MA, Critchley HD, (2007) Interoceptive basis to craving. Neuron 54: 183-186. (Pubitemid 46561204)
22. Hearing MC, Miller SW, See RE, McGinty JF, (2008) Relapse to cocaine seeking increases activity-regulated gene expression differentially in the prefrontal cortex of abstinent rats. Psychopharmacology (Berl) 198: 77-91.
23. Hiranita T, Soto PL, Newman AH, Katz JL, (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329: 677-686.
24. Kalivas PW, (2008) Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res 14: 185-189.
25. Kalivas PW, McFarland K, (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44-56. (Pubitemid 36851162)
26. Koob GF, Le Moal M, (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58. (Pubitemid 27446270)
27. Le FB, Diaz J, Sokoloff P, (2005) A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 16: 175-178. (Pubitemid 40250395)
28. Lew M, (2007) Good statistical practice in pharmacology. Problem 2. Br J Pharmacol 152: 299-303. (Pubitemid 47511253)
29. Lu H, Cheng PL, Lim BK, Khoshnevisrad N, Poo MM, (2010) Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron 67: 821-833.
30. Macedo DS, Correia EE, Vasconcelos SM, Aguiar LM, Viana GS, Sousa FC, (2004) Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell Mol Neurobiol 24: 129-136. (Pubitemid 38233736)
31. Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF, (2007) A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming. Prog Neuropsychopharmacol Biol Psychiatry 31: 593-599. (Pubitemid 46467037)
32. McGinty JF, Whitfield TW Jr, Berglind WJ, (2010) Brain-derived neurotrophic factor and cocaine addiction. Brain Res 1314: 183-193.
33. Melis M, Spiga S, Diana M, (2005) The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 63: 101-154. (Pubitemid 43631260)
34. Mihindou C, Vouillac C, Koob GF, Ahmed SH, (2011) Preclinical validation of a novel cocaine exposure therapy for relapse prevention. Biol Psychiatry 70: 593-598.
35. Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J, (2009) Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 101: 34-41.
36. Paxinos G, Watson CR, (2007) The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
37. Peters J, Kalivas PW, Quirk GJ, (2009) Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem 16: 279-288.
38. Preti A, (2000) Vanoxerine National Institute on Drug Abuse. Curr Opin Investig Drugs 1: 241-251.
39. Raje S, Cornish J, Newman AH, Cao J, Katz JL, Eddington ND, (2005) Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharm Res 22: 603-612. (Pubitemid 40603258)
40. Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM, (2000) Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol 20: 61-68. (Pubitemid 30056355)
41. Rossetti ZL, Hmaidan Y, Gessa GL, (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221: 227-234.
42. Rothman RB, Baumann MH, Prisinzano TE, Newman AH, (2008) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 75: 2-16. (Pubitemid 350235399)
43. Shaham Y, Shalev U, Lu L, De WH, Stewart J, (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20. (Pubitemid 36851158)
44. Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J, (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98: 1137-1141. (Pubitemid 36936500)
45. Skjoldager P, Winger G, Woods JH, (1993) Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend 33: 31-39. (Pubitemid 23219907)
46. Sorge RE, Rajabi H, Stewart J, (2005) Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology 30: 1681-1692. (Pubitemid 43086025)
47. Tanda G, Newman AH, Katz JL, (2009) Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. Adv Pharmacol 57: 253-289.
48. Tella SR, (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51: 687-692.
49. Velazquez-Sanchez C, Ferragud A, Hernandez-Rabaza V, Nacher A, Merino V, Carda M, Murga J, Canales JJ, (2009) The dopamine uptake inhibitor 3 alpha-[bis(4′-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. Neuropsychopharmacology 34: 2497-2507.
50. Velazquez-Sanchez C, Ferragud A, Murga J, Carda M, Canales JJ, (2010a) The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. Eur Neuropsychopharmacol 20: 501-508.
51. Velazquez-Sanchez C, Ferragud A, Renau-Piqueras J, Canales JJ, (2010b) Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. Int J Neuropsychopharmacol 24: 1-11.
52. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ, (2002) Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 78: 610-624. (Pubitemid 36268682)
53. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, Dewey SL, Hitzemann R, Lieberman J, (1996) Relationship between psychostimulant-induced 'high' and dopamine transporter occupancy. Proc Natl Acad Sci U S A 93: 10388-10392.
54. Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS, (2011) Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry doi: 10.1038/mp.2011.86. [Epub ahead of print].
55. Weiss F, Markou A, Lorang MT, Koob GF, (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593: 314-318.
56. Zhou Y, Michelhaugh SK, Schmidt CJ, Liu JS, Bannon MJ, Lin Z, (2011) Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects. Addict Biol doi: 10.1111/j.1369-1600.2011.00391.x. [Epub ahead of print].
57. Ziolkowska B, Kielbinski M, Gieryk A, Soria G, Maldonado R, Przewlocki R, (2011) Regulation of the immediate-early genes arc and zif268 in a mouse operant model of cocaine seeking reinstatement. J Neural Transm 118: 877-887.